This difference in disease duration may explain why differences in SERT binding were less profound in the present study in early-stage PD patients, and why we failed to find lower binding in the thalamus in PD and DLB, and in the hypothalamus in PD. The gene discussed is SLC6A4; the disease is Lewy body dementia.